Thin and Slim Fataway Ultimate Stack with Chromium
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
1,739 recalls · Class I, newest first
Reason Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Subpotent Drug
Reason Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.
Reason Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.
Reason Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
Reason Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Reason Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution
Reason Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.
Reason Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.
Reason Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes.
Reason Marketed Without An Approved NDA/ANDA: Dietary supplements contains undeclared sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling.
Reason Marketed Without an Approved NDA/ANDA: FDA sampling and analysis confirmed the presence of sibutramine and desmethylsibutramine.
Reason Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared diclofenac, a prescription non-steroidal anti-inflammatory drug, and chlorpheniramine, an over-the-counter antihistimine, making this an unapproved drug.
Reason Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.
Reason Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.
Reason Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.
Reason Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.
Reason Presence of Particulate Matter
Reason Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.